Cover Image
Market Research Report

Global Continuous Subcutaneous Insulin Therapy Devices (CSITD) Market 2019-2023

Published by TechNavio (Infiniti Research Ltd.) Product code 756746
Published Content info 111 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Continuous Subcutaneous Insulin Therapy Devices (CSITD) Market 2019-2023
Published: December 3, 2018 Content info: 111 Pages
Description

About this market:

The rising partnerships to gain prominence in the market. Vendors are entering into strategic alliances and partnerships for integration of available and emerging technologies into their products. Such partnerships will help the market to grow. Technavio's analysts have predicted that the continuous subcutaneous insulin therapy devices market will register a CAGR of more than 9% by 2023.

Market Overview:

Rise in awareness about diabetes

The rise in prevalence of diabetes has resulted in increasing awareness efforts by various organizations globally. Programs such as the Diabetes Activities Under State Public Health Actions increase the participation of people.

Rise in product recalls

The growth of the market is hindered by product recalls. Product recalls affect the sales of a company negatively, which results in a decline in it market share. Also, they affect the brand image of vendors, thereby reducing profit margins.

For the detailed list of factors that will drive and challenge the growth of the continuous subcutaneous insulin therapy devices market during the 2019-2023, view our report.

Competitive Landscape:

The market appears to be concentrated and with the presence of several companies including Medtronic and Tandem Diabetes Care the competitive environment is quite intense. Factors such as the rising partnerships and the rise in awareness about diabetes, will provide considerable growth opportunities to continuous subcutaneous insulin therapy devices manufactures. Cellnovo, F. Hoffmann-La Roche, Insulet, Medtronic, and Tandem Diabetes Care are some of the major companies covered in this report.

Table of Contents
Product Code: IRTNTR30346

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Tethered - Market size and forecast 2018-2023
  • Patch - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

  • Technological advances
  • Increase in grants for product development
  • Rise in strategic partnerships

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Cellnovo
  • F. Hoffmann-La Roche
  • Insulet
  • Medtronic
  • Tandem Diabetes Care

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations

List of Exhibits

  • Exhibit 01: Years in consideration
  • Exhibit 02: Global medical devices market
  • Exhibit 03: Segments of global medical devices market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Product - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by product
  • Exhibit 19: Tethered - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Tethered - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Patch - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Patch - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Market opportunity by product
  • Exhibit 24: Customer landscape
  • Exhibit 25: Market share by geography 2018-2023 (%)
  • Exhibit 26: Geographic comparison
  • Exhibit 27: Americas - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 28: Americas - Year-over-year growth 2019-2023 (%)
  • Exhibit 29: Top 3 countries in Americas
  • Exhibit 30: EMEA - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: EMEA - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Top 3 countries in EMEA
  • Exhibit 33: APAC - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: APAC - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Top 3 countries in APAC
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Decision framework
  • Exhibit 39: Patients diagnosed with diabetes in US 1995-2015
  • Exhibit 40: Rates of children aged under 14 years with type 1 diabetes per 1,000 population 2015
  • Exhibit 41: Product launches
  • Approval year
  • Regulatory body
  • Description
  • Exhibit 42: Product recalls in global CSITD market
  • Exhibit 43: Impact of drivers and challenges
  • Exhibit 44: Vendor landscape
  • Exhibit 45: Landscape disruption
  • Exhibit 46: Vendors covered
  • Exhibit 47: Vendor classification
  • Exhibit 48: Market positioning of vendors
  • Exhibit 49: Cellnovo - Vendor overview
  • Exhibit 50: Cellnovo - Organizational developments
  • Exhibit 51: Cellnovo - Geographic focus
  • Exhibit 52: Cellnovo - Key offerings
  • Exhibit 53: F. Hoffmann-La Roche - Vendor overview
  • Exhibit 54: F. Hoffmann-La Roche - Business segments
  • Exhibit 55: F. Hoffmann-La Roche - Organizational developments
  • Exhibit 56: F. Hoffmann-La Roche - Geographic focus
  • Exhibit 57: F. Hoffmann-La Roche - Segment focus
  • Exhibit 58: F. Hoffmann-La Roche - Key offerings
  • Exhibit 59: Insulet - Vendor overview
  • Exhibit 60: Insulet - Organizational developments
  • Exhibit 61: Insulet - Geographic focus
  • Exhibit 62: Insulet - Key offerings
  • Exhibit 63: Medtronic - Vendor overview
  • Exhibit 64: Medtronic - Business segments
  • Exhibit 65: Medtronic - Organizational developments
  • Exhibit 66: Medtronic - Geographic focus
  • Exhibit 67: Medtronic - Segment focus
  • Exhibit 68: Medtronic - Key offerings
  • Exhibit 69: Tandem Diabetes Care - Vendor overview
  • Exhibit 70: Tandem Diabetes Care - Organizational developments
  • Exhibit 71: Tandem Diabetes Care - Key offerings
  • Exhibit 72: Validation techniques employed for market sizing
  • Exhibit 73: List of abbreviations
Back to Top